{"filing":{"accession_number":"0001213900-26-073998","cik":"0001860657","ticker":"ALLR","company_name":"Allarity Therapeutics, Inc.","form":"8-K","filing_date":"2026-07-01","report_date":null,"primary_document":"ea0296615-8k_allarity.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1860657/000121390026073998/ea0296615-8k_allarity.htm"},"events":[{"id":15310,"run_id":13662,"accession_number":"0001213900-26-073998","anchor_item_number":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.85,"summary":"The filing's primary disclosure under Item 5.07 reports the results of Allarity's June 26, 2026 annual stockholders meeting, including voting outcomes on seven proposals (director election, auditor ratification, equity plan amendment, executive compensation advisory vote, share issuance approval, certificate amendment, and meeting adjournment). While Item 8.01 also discloses a USPTO patent grant for the stenoparib DRP® companion diagnostic, the 8-K structure and content center on the shareholder vote results as the material event triggering the filing.","company_name":"Allarity Therapeutics, Inc.","ticker":"ALLR","filing_date":"2026-07-01","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":13026,"accession_number":"0001213900-26-073998","item_number":null,"item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"The filing's primary disclosure under Item 5.07 reports the results of Allarity's June 26, 2026 annual stockholders meeting, including voting outcomes on seven proposals (director election, auditor ratification, equity plan amendment, executive compensation advisory vote, share issuance approval, certificate amendment, and meeting adjournment). While Item 8.01 also discloses a USPTO patent grant for the stenoparib DRP® companion diagnostic, the 8-K structure and content center on the shareholder vote results as the material event triggering the filing.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-01T12:06:55.137172+00:00","company_name":"Allarity Therapeutics, Inc.","ticker":"ALLR","filing_date":"2026-07-01"}]}